Amarantus Bioscience Holdings Inc AMBS:OTC Pink - Current Information

Last Price$0.0083NASDAQ Last Trade (15-minute delayed) as of 1:56PM ET 12/01/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change-0.002(18.63%)
Bid (Size)$0.0083 (173,750)
Ask (Size)$0.009 (556,500)
Day Low / High$0.0083 - 0.011
Volume3.1 M

Read more news Recent News

No news stories available at this time.

View all Commentary and Analysis

No news stories available at this time.

Company Profile

Business DescriptionAmarantus BioScience Holdings, Inc. is a biopharmaceutical company. The company engages in developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. It focuses on acquiring product and technology rights, raising capital, and performing research and development. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in New York, NY. View company web site for more details
Address45 Wall Street
New York, New York 10005
Number of EmployeesN/A
President, Chief Executive Officer & DirectorGerald E. Commissiong
Director & Chief Scientific OfficerJohn W. Commissiong
Independent Director & Compliance OfficerRobert L. Harris
Executive VP-Operations & Program ManagementElise Brownell

Company Highlights

Price Open$0.01
Previous Close$0.01
52 Week Range$0.0033 - 0.02
Market Capitalization$3.7 M
Shares Outstanding443.3 M
SectorHealth Technology
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share$0.00
Beta vs. S&P 500N/A
Net Profit Margin60.47%
Return on Equity-0.34%

Analyst Ratings as of 07/13/2015

Consensus RecommendationConsensus Icon
Powered by Factset